Cost-Utility Analysis Of Abiraterone Versus Enzalutamide In The Treatment Of Metastatic Castration-Resistant Prostate Cancer After Failure Of Androgen Deprivation Therapy
                        AuthID
P-00R-G10
                
    P-00R-G10
© 2025 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service